Pancreatic Cancer Research

ResearcherChangzhi Medical CollegeActive in the last 2 years

Changhong Lian

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3215-8673; OpenAlex author ID A5043634468. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
10
Papers, trials and grants by year

2023: 2 papers · 2024: 1 paper

Papers 3

  1. Role of a novel circRNA-CGNL1 in regulating pancreatic cancer progression via NUDT4-HDAC4-RUNX2-GAMT-mediated apoptosis. Co-author DOI 10.1186/s12943-023-01923-7↗
  2. Linc-UROD stabilizes ENO1 and PKM to strengthen glycolysis, proliferation and migration of pancreatic cancer cells. Last author DOI 10.1016/j.tranon.2022.101583↗
  3. circPTPN22 attenuates immune microenvironment of pancreatic cancer via STAT3 acetylation. Last author DOI 10.1038/s41417-021-00382-w↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Chuang Chen · 2 shared papers, 2023–2024 · strength 0.37
  2. Yuan He · 2 shared papers, 2023 · strength 0.36
  3. Huiqing Zhang · 1 shared paper, 2023 · strength 0.18
  4. Hao Hu · 1 shared paper, 2023 · strength 0.18
  5. Yufeng Zhang · 1 shared paper, 2024 · strength 0.18
  6. Hao Yuan · 1 shared paper, 2024 · strength 0.18
  7. Xinjian Liu · 1 shared paper, 2024 · strength 0.18
  8. Yuan He · 1 shared paper, 2024 · strength 0.18
  9. Kuirong Jiang · 1 shared paper, 2024 · strength 0.18
  10. Hao Hu · 1 shared paper, 2023 · strength 0.17

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.